Aurobindo gets tentative approval for generic HIV drug

2/23/2009

ROCKVILLE, Md. The Food and Drug Administration has given tentative approval to Aurobindo Pharma's tenofovir disoproxil fumarate tablets in the 300 mg strength, a generic version of an HIV drug, agency records show.

The tablets are a generic version of Gilead Sciences' Viread. Viread, the hepatitis B drug Hepsera (adefovir dipivoxil) and the HIV drug Emtriva (emtricitabine) had combined sales of $245.3 million in fourth quarter of 2008, according to a Gilead statement.

Viread will lose patent protection in 2017, according to the FDA's Orange Book.

X
This ad will auto-close in 10 seconds